ATL‐1, an analogue of aspirin‐triggered lipoxin A₄, is a potent inhibitor of several steps in angiogenesis induced by vascular endothelial growth factor

Abstract

The synthetic 15-epi-lipoxin analogue, ATL-1, is a highly potent molecule exerting its effects on multiple steps of the VEGF-induced angiogenesis.